Global Immunoglobulin Products Market 2016-2020 - Product Image

Global Immunoglobulin Products Market 2016-2020

  • ID: 3678066
  • Report
  • Region: Global
  • 84 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abeona Therapeutics
  • Baxalta
  • Emergent Biosolutions
  • Grifols SA
  • Innate Pharma
  • Kedrion SpA
  • MORE
About Immunoglobulin Products

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM.

In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.

The analysts forecast the global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

- Baxalta
- Biotest Pharmaceuticals Corp.
- CSL Ltd.
- Grifols SA
- Kedrion SpA
- Octapharma

Other prominent vendors

- Abeona Therapeutics
- Admabiologics
- Anthera
- Beijing Tiantan Biological Products (China)
- Bharat Serums and Vaccines (India)
- Bio Products Laboratory
- China Biologic Products (China)
- Emergent Biosolutions
- Gliknik
- Greencross
- Hansamedical
- Hualan Biological Engineering (China)
- Immunomedics
- Innate Pharma
- Integrated Biotherapeutics
- Janssen Pharmaceuticals
- Kamada
- LFB Group (France)
- Mitsubishi Tanabe Pharma
- Momenta Pharma
- Patrys
- Shanghai RAAS Blood Products (China)
- Sichuan Yuanda Shuyang Pharmaceutical (China)
- Sorrento Therapeutics

Market drivers

- Growing aging population

Market challenges

- High cost of therapy

Market trends

- Patient assistance programs

Key questions answered in this report:

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abeona Therapeutics
  • Baxalta
  • Emergent Biosolutions
  • Grifols SA
  • Innate Pharma
  • Kedrion SpA
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
  • Assumptions
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Plasma products: An overview
  • Components of blood plasma
  • Manufacturing process of plasma products
  • Clinical uses of plasma
  • Cost of plasma therapeutics
PART 06: Regulation of plasma products

PART 07: Pipeline portfolio
  • Information on few pipeline candidates
PART 08: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 09: Market segmentation by type of immunoglobulins

PART 10: Market segmentation by application
  • Immunodeficiency diseases
  • Hypogammaglobulinemia
  • CIDP
  • Congenital AIDS
  • CLL
  • Myasthenia gravis
  • MMN
  • ITP
  • Kawasaki disease
  • Guillain-Barré syndrome
  • Others
PART 11: Market segmentation by ROA
  • IVIG products
  • SCIG products
  • IMIG products
PART 12: Market segmentation by volume
  • Market overview
  • Immunoglobulin products market by volume in Americas
  • Immunoglobulin products market by volume in EMEA
  • Immunoglobulin products market by volume in APAC
PART 13: Geographical segmentation
  • Immunoglobulin products market in Americas
  • Immunoglobulin products market in EMEA
  • Immunoglobulin products market in APAC
PART 14: Market drivers
  • Growing older population
  • Increase in individuals with PID
  • Promising pipeline
  • Approval of immunoglobulins to treat neuroimmunological disorders
  • Rise in demand for IVIG therapies
PART 15: Impact of drivers

PART 16: Market challenges
  • High cost of therapy
  • Product recalls by US FDA
  • Limited plasma fractionation capacity
  • Post-transfusion adverse reactions
  • Stringent regulatory guidelines
PART 17: Impact of drivers and challenges

PART 18: Market trends
  • Patient assistance programs
  • Strategic alliances and M&A
  • Increased use of synthetic/recombinant products
  • Rise in awareness of PID
PART 19: Vendor landscape
  • Competitive scenario
  • Market share analysis 2015
  • CSL
  • Baxalta
  • Grifols
  • Octapharma
  • Kedrion
  • Biotest Pharmaceuticals
  • Other prominent vendors
PART 20: Appendix
  • List of abbreviations
PART 21: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Composition of blood
Exhibit 03: Composition of plasma
Exhibit 04: Total collection of plasma in US 2010-2014 (in liters)
Exhibit 05: Projected fractionation capacity of manufacturing units in US and EU (millions of liters/annum)
Exhibit 06: Process of procurement and manufacturing of plasma products
Exhibit 07: Regulatory policies of plasma protein therapy lifecycle
Exhibit 08: Pipeline molecules for immunoglobulin products
Exhibit 09: Pipeline share of immunoglobulin products 2015
Exhibit 10: Global immunoglobulin products market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Global immunoglobulin products market segment by type of immunoglobulins
Exhibit 13: Global immunoglobulin products market share by type of immunoglobulins 2015
Exhibit 14: Global immunoglobulin products market segmentation by application
Exhibit 15: Global immunoglobulin products market share by application
Exhibit 16: Global immunoglobulin products market segment by ROA
Exhibit 17: Global immunoglobulin products market share by ROA2015
Exhibit 18: Global IVIG products market 2015-2020 ($ billions)
Exhibit 19: Global SCIG products market 2015-2020 ($ billions)
Exhibit 20: Global IMIG products market 2015-2020 ($ billions)
Exhibit 21: Global immunoglobulin products market revenue by ROA 2015-2020 ($ billions)
Exhibit 22: Global immunoglobulin products market YoY revenue and growth based on ROA 2015-2020 ($ billions)
Exhibit 23: Global immunoglobulin products market by volume 2015
Exhibit 24: Global immunoglobulin products by volume 2015 and 2020 (tons)
Exhibit 25: Global immunoglobulin products market by volume 2015-2020 (tons)
Exhibit 26: Average immunoglobulin consumption by country (Kilograms per million people) 2012
Exhibit 27: Immunoglobulin products market in Americas by volume 2015-2020 (tons)
Exhibit 28: Global immunoglobulin products market by volume 2015-2020 (tons)
Exhibit 29: Immunoglobulin products market in EMEA by volume 2015-2020 (tons)
Exhibit 30: Global immunoglobulin products market by geography 2015
Exhibit 31: Global immunoglobulin products market revenue by geography 2015-2020 ($ billions)
Exhibit 32: Immunoglobulin products market in Americas 2015-2020 ($ billions)
Exhibit 33: Immunoglobulin products market in EMEA 2015-2020 ($ billions)
Exhibit 34: Immunoglobulin products market in APAC 2015-2020 ($ billions)
Exhibit 35: Global immunoglobulin products market YoY revenue and growth based on geography 2015-2020
Exhibit 36: Population aged 60 years and over: World, developed, and developing regions (millions)
Exhibit 37: Impact of drivers
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Global immunoglobulin products market share analysis 2015
Exhibit 40: Market share analysis of top vendors 2015
Exhibit 41: CSL: Immunoglobulins products segmentation
Exhibit 42: Key takeaways
Exhibit 43: Baxalta: Product categories by revenue 2015
Exhibit 44: Baxalta: YoY revenue comparison of immunoglobulin therapy area 2014 and 2015
Exhibit 45: Baxalta: Geographic segmentation of immunoglobulin therapies by revenue 2015
Exhibit 46: CSL: Key takeaways
Exhibit 47: Grifols: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions)
Exhibit 48: Grifols: Key takeaways
Exhibit 49: Octapharma: Key takeaways
Exhibit 50: Kedrion: Key takeaways
Exhibit 51: Biotest: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abeona Therapeutics
  • Baxalta
  • Emergent Biosolutions
  • Grifols SA
  • Innate Pharma
  • Kedrion SpA
  • MORE
New Report Released: – Global Immunoglobulin Products Market 2016-2020

The author of the report recognizes the following companies as the key players in the Global Immunoglobulin Products Market: Baxalta, Biotest Pharmaceuticals Corp., CSL Ltd., Grifols SA, Kedrion SpA, and Octapharma.

Other Prominent Vendors in the market are: Abeona Therapeutics, Admabiologics, Anthera, Beijing Tiantan Biological Products (China), Bharat Serums and Vaccines (India), Bio Products Laboratory, China Biologic Products (China), Emergent Biosolutions, Gliknik, Greencross, Hansamedical, Hualan Biological Engineering (China), Immunomedics, Innate Pharma, Integrated Biotherapeutics, Janssen Pharmaceuticals, Kamada, LFB Group (France), Mitsubishi Tanabe Pharma, Momenta Pharma, Patrys, Shanghai RAAS Blood Products (China), Sichuan Yuanda Shuyang Pharmaceutical (China), and Sorrento Therapeutics.

Commenting on the report, an analyst from the research team said: “As plasma therapeutics are often expensive, vendors provide co-pay assistance to patients to enable the purchase of these drugs. For instance, Baxter's Gammagard liquid support program provides financial assistance to individuals with primary immunodeficiency. According to the Gammagard Liquid SubQ CoPay card, an eligible patient receiving treatment with Gammagard Liquid SubQ for primary immunodeficiency is entitled to save up to $2,500 on the coinsurance/co-payment costs over a 12-month period.”

According to the report, growing older population is driving the market growth. The immune system becomes weak with age, causing many immune deficiency syndromes. Individuals with immune deficiency require immunoglobulin products for proper functioning of the immune system.

Further, the report states that immunoglobulin products are produced from plasma, and obtaining high-quality plasma is an expensive and challenging exercise. Moreover, the cost of immunoglobulin is dependent on the availability of human donors. Fractionation of plasma is the standard method of producing immunoglobulins and is a highly complex procedure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Baxalta
- Biotest Pharmaceuticals Corp.
- CSL Ltd.
- Grifols SA
- Kedrion SpA
- Octapharma
- Abeona Therapeutics
- Admabiologics
- Anthera
- Beijing Tiantan Biological Products (China)
- Bharat Serums and Vaccines (India)
- Bio Products Laboratory
- China Biologic Products (China)
- Emergent Biosolutions
- Gliknik
- Greencross
- Hansamedical
- Hualan Biological Engineering (China)
- Immunomedics
- Innate Pharma
- Integrated Biotherapeutics
- Janssen Pharmaceuticals
- Kamada
- LFB Group (France)
- Mitsubishi Tanabe Pharma
- Momenta Pharma
- Patrys
- Shanghai RAAS Blood Products (China)
- Sichuan Yuanda Shuyang Pharmaceutical (China)
- Sorrento Therapeutics
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll